| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TCRR | TCR2 THERAPEUTICS INC. | GADICKE ANSBERT | Director | May 22, 2023 | Sale | $1.06 | 248,439 | 263,839 | 374,171 | May 24, 2023, 04:38 PM | |
| ALVR | Allovir, Inc. | GADICKE ANSBERT | Director | Jul 28, 2022 | Option Exercise | $4.61 | 3,253,796 | 15,000,000 | 16,674,766 | Aug 01, 2022, 04:34 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Jan 04, 2022 | Sale | $42.66 | 215,122 | 9,176,849 | 4,571,618 | Jan 06, 2022, 04:12 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Jan 05, 2022 | Sale | $42.03 | 30,347 | 1,275,484 | 4,484,728 | Jan 06, 2022, 04:12 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Dec 03, 2021 | Sale | $34.79 | 33,749 | 1,173,965 | 4,784,185 | Dec 07, 2021, 06:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Dec 06, 2021 | Sale | $32.59 | 17,083 | 556,766 | 4,765,665 | Dec 07, 2021, 06:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Dec 07, 2021 | Sale | $33.22 | 32,558 | 1,081,697 | 4,732,696 | Dec 07, 2021, 06:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Dec 01, 2021 | Sale | $34.28 | 20,742 | 710,988 | 4,886,448 | Dec 02, 2021, 06:53 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Dec 02, 2021 | Sale | $33.96 | 62,230 | 2,113,193 | 4,826,021 | Dec 02, 2021, 06:53 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Nov 30, 2021 | Sale | $35.09 | 56,801 | 1,993,236 | 4,943,551 | Dec 02, 2021, 06:53 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Nov 26, 2021 | Sale | $35.75 | 21,210 | 758,282 | 4,980,974 | Nov 30, 2021, 04:49 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Nov 29, 2021 | Sale | $34.49 | 17,356 | 598,543 | 4,953,860 | Nov 30, 2021, 04:49 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Nov 23, 2021 | Sale | $36.22 | 33,476 | 1,212,340 | 5,053,334 | Nov 24, 2021, 06:38 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Nov 24, 2021 | Sale | $36.29 | 60,808 | 2,206,509 | 5,044,587 | Nov 24, 2021, 06:38 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Nov 22, 2021 | Sale | $37.52 | 35,333 | 1,325,817 | 5,105,986 | Nov 24, 2021, 06:38 PM | |
| TRDA | Entrada Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Nov 02, 2021 | Buy | $20.00 | 100,000 | 2,000,000 | 4,425,784 | Nov 04, 2021, 05:37 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Oct 15, 2021 | Sale | $27.62 | 18,295 | 505,300 | 5,150,947 | Oct 18, 2021, 04:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Oct 18, 2021 | Sale | $27.14 | 10,320 | 280,085 | 5,137,214 | Oct 18, 2021, 04:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Oct 13, 2021 | Sale | $27.13 | 35,023 | 950,174 | 5,211,548 | Oct 14, 2021, 05:26 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Oct 14, 2021 | Sale | $27.30 | 45,719 | 1,248,129 | 5,165,829 | Oct 14, 2021, 05:26 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Oct 12, 2021 | Sale | $27.09 | 14,260 | 386,303 | 5,246,571 | Oct 14, 2021, 05:26 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Oct 07, 2021 | Sale | $27.00 | 1,922 | 51,894 | 5,345,915 | Oct 12, 2021, 04:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Oct 08, 2021 | Sale | $27.01 | 3,400 | 91,834 | 5,342,515 | Oct 12, 2021, 04:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Oct 11, 2021 | Sale | $27.24 | 81,684 | 2,225,072 | 5,260,831 | Oct 12, 2021, 04:33 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Oct 04, 2021 | Sale | $27.06 | 34,659 | 937,873 | 5,347,837 | Oct 05, 2021, 04:31 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Oct 01, 2021 | Sale | $27.00 | 11,471 | 309,717 | 5,382,496 | Oct 05, 2021, 04:31 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 28, 2021 | Sale | $27.00 | 32,154 | 868,158 | 5,397,803 | Sep 30, 2021, 05:05 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 30, 2021 | Sale | $27.00 | 3,836 | 103,572 | 5,393,967 | Sep 30, 2021, 05:05 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 24, 2021 | Sale | $27.81 | 8,221 | 228,626 | 5,449,412 | Sep 27, 2021, 05:51 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 27, 2021 | Sale | $27.09 | 19,455 | 527,036 | 5,429,957 | Sep 27, 2021, 05:51 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 23, 2021 | Sale | $27.97 | 61,800 | 1,728,432 | 5,458,833 | Sep 27, 2021, 05:51 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 21, 2021 | Sale | $27.47 | 32,858 | 902,609 | 5,543,354 | Sep 23, 2021, 04:18 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 22, 2021 | Sale | $27.54 | 23,921 | 658,784 | 5,519,433 | Sep 23, 2021, 04:18 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 16, 2021 | Sale | $28.47 | 35,565 | 1,012,536 | 5,693,358 | Sep 20, 2021, 06:30 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 17, 2021 | Sale | $28.82 | 76,473 | 2,203,952 | 5,616,885 | Sep 20, 2021, 06:30 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 20, 2021 | Sale | $27.49 | 40,673 | 1,117,965 | 5,599,142 | Sep 20, 2021, 06:30 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 16, 2021 | Sale | $29.06 | 432 | 12,554 | 244,551 | Sep 20, 2021, 05:30 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 16, 2021 | Sale | $29.06 | 3,124 | 90,783 | 7,648,268 | Sep 20, 2021, 05:30 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 14, 2021 | Sale | $27.58 | 36,081 | 995,198 | 5,775,322 | Sep 16, 2021, 04:46 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 15, 2021 | Sale | $27.80 | 40,336 | 1,121,535 | 5,730,582 | Sep 16, 2021, 04:46 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 15, 2021 | Sale | $29.16 | 6,425 | 187,353 | 7,651,392 | Sep 16, 2021, 04:44 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 14, 2021 | Sale | $29.17 | 982 | 28,645 | 245,871 | Sep 16, 2021, 04:44 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 14, 2021 | Sale | $29.17 | 7,106 | 207,282 | 7,657,817 | Sep 16, 2021, 04:44 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 15, 2021 | Sale | $29.16 | 888 | 25,894 | 244,983 | Sep 16, 2021, 04:44 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 10, 2021 | Sale | $28.30 | 22,643 | 640,691 | 5,852,455 | Sep 13, 2021, 07:02 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 13, 2021 | Sale | $27.64 | 35,785 | 989,097 | 5,805,340 | Sep 13, 2021, 07:02 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 09, 2021 | Sale | $28.97 | 38,028 | 1,101,671 | 5,863,768 | Sep 13, 2021, 07:02 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 10, 2021 | Sale | $29.04 | 820 | 23,813 | 247,350 | Sep 13, 2021, 06:22 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 10, 2021 | Sale | $29.04 | 5,931 | 172,236 | 7,668,518 | Sep 13, 2021, 06:22 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 13, 2021 | Sale | $29.10 | 497 | 14,463 | 246,853 | Sep 13, 2021, 06:22 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 13, 2021 | Sale | $29.10 | 3,595 | 104,615 | 7,664,923 | Sep 13, 2021, 06:22 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 09, 2021 | Sale | $29.35 | 1,898 | 55,706 | 248,170 | Sep 13, 2021, 06:22 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 09, 2021 | Sale | $29.35 | 13,727 | 402,887 | 7,674,449 | Sep 13, 2021, 06:22 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 07, 2021 | Sale | $29.18 | 50,996 | 1,488,063 | 5,953,372 | Sep 08, 2021, 07:19 PM | |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Sep 08, 2021 | Sale | $28.65 | 20,236 | 579,723 | 5,903,369 | Sep 08, 2021, 07:19 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 08, 2021 | Sale | $29.11 | 10,842 | 315,611 | 7,688,176 | Sep 08, 2021, 06:17 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 03, 2021 | Sale | $29.60 | 1,760 | 52,096 | 255,032 | Sep 08, 2021, 06:17 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 03, 2021 | Sale | $29.60 | 12,731 | 376,838 | 7,724,085 | Sep 08, 2021, 06:17 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 07, 2021 | Sale | $29.04 | 3,465 | 100,624 | 251,567 | Sep 08, 2021, 06:17 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 07, 2021 | Sale | $29.04 | 25,067 | 727,946 | 7,699,018 | Sep 08, 2021, 06:17 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 08, 2021 | Sale | $29.11 | 1,499 | 43,636 | 250,068 | Sep 08, 2021, 06:17 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 02, 2021 | Sale | $29.46 | 15,757 | 464,201 | 7,736,816 | Sep 02, 2021, 05:25 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Aug 31, 2021 | Sale | $29.82 | 392 | 11,689 | 259,975 | Sep 02, 2021, 05:25 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Aug 31, 2021 | Sale | $29.82 | 2,838 | 84,625 | 7,759,840 | Sep 02, 2021, 05:25 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 01, 2021 | Sale | $29.47 | 790 | 23,281 | 258,970 | Sep 02, 2021, 05:25 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 01, 2021 | Sale | $29.47 | 5,714 | 168,392 | 7,752,573 | Sep 02, 2021, 05:25 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Sep 02, 2021 | Sale | $29.46 | 2,178 | 64,164 | 256,792 | Sep 02, 2021, 05:25 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Aug 27, 2021 | Sale | $29.09 | 1,846 | 53,700 | 264,437 | Aug 31, 2021, 04:48 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Aug 27, 2021 | Sale | $29.09 | 13,357 | 388,555 | 7,792,126 | Aug 31, 2021, 04:48 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Aug 30, 2021 | Sale | $29.30 | 4,285 | 125,550 | 260,152 | Aug 31, 2021, 04:48 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Aug 30, 2021 | Sale | $29.30 | 31,001 | 908,329 | 7,761,125 | Aug 31, 2021, 04:48 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Aug 25, 2021 | Sale | $29.09 | 1,713 | 49,831 | 7,805,483 | Aug 25, 2021, 07:41 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Aug 23, 2021 | Sale | $29.11 | 7,376 | 214,715 | 273,545 | Aug 25, 2021, 07:41 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Aug 23, 2021 | Sale | $29.11 | 53,359 | 1,553,281 | 7,858,018 | Aug 25, 2021, 07:41 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Aug 24, 2021 | Sale | $29.48 | 7,025 | 207,097 | 266,520 | Aug 25, 2021, 07:41 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Aug 24, 2021 | Sale | $29.48 | 50,882 | 1,500,001 | 7,807,196 | Aug 25, 2021, 07:41 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Aug 25, 2021 | Sale | $29.09 | 237 | 6,894 | 266,283 | Aug 25, 2021, 07:41 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Aug 11, 2021 | Sale | $29.05 | 2,510 | 72,915 | 7,911,377 | Aug 12, 2021, 04:54 PM | |
| CGEM | Cullinan Oncology, Inc. | GADICKE ANSBERT | Director | Aug 11, 2021 | Sale | $29.05 | 347 | 10,080 | 280,921 | Aug 12, 2021, 04:54 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jul 09, 2021 | Sale | $33.06 | 4,067 | 134,455 | 3,940,497 | Jul 13, 2021, 04:21 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jul 12, 2021 | Sale | $33.59 | 58,012 | 1,948,413 | 3,883,196 | Jul 13, 2021, 04:21 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jun 28, 2021 | Sale | $34.18 | 16,500 | 564,042 | 3,949,964 | Jun 30, 2021, 05:25 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jun 29, 2021 | Sale | $33.29 | 2,700 | 89,883 | 3,944,564 | Jun 30, 2021, 05:25 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jun 21, 2021 | Sale | $34.50 | 37,588 | 1,296,858 | 4,029,450 | Jun 23, 2021, 05:38 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jun 22, 2021 | Sale | $33.44 | 3,800 | 127,081 | 3,994,291 | Jun 23, 2021, 05:38 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jun 23, 2021 | Sale | $32.98 | 1,410 | 46,502 | 3,992,452 | Jun 23, 2021, 05:38 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jun 17, 2021 | Sale | $33.80 | 32,518 | 1,099,039 | 4,045,958 | Jun 21, 2021, 04:06 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jun 18, 2021 | Sale | $33.66 | 9,000 | 302,963 | 4,038,449 | Jun 21, 2021, 04:06 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jun 14, 2021 | Sale | $33.09 | 2,000 | 66,180 | 4,080,995 | Jun 16, 2021, 05:09 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jun 16, 2021 | Sale | $33.33 | 4,227 | 140,886 | 4,076,768 | Jun 16, 2021, 05:09 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jun 08, 2021 | Sale | $33.20 | 26,200 | 869,825 | 4,135,380 | Jun 10, 2021, 04:04 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jun 09, 2021 | Sale | $34.68 | 35,230 | 1,221,633 | 4,107,363 | Jun 10, 2021, 04:04 PM | |
| HARP | Harpoon Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Jun 01, 2021 | Sale | $20.44 | 18,491 | 377,956 | 6,353,213 | Jun 02, 2021, 06:09 PM | |
| HARP | Harpoon Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | Jun 02, 2021 | Sale | $20.50 | 25,118 | 514,919 | 6,328,095 | Jun 02, 2021, 06:09 PM | |
| HARP | Harpoon Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | May 28, 2021 | Sale | $21.12 | 13,885 | 293,315 | 6,374,904 | Jun 02, 2021, 06:09 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | May 28, 2021 | Sale | $32.67 | 16,742 | 546,961 | 4,223,930 | Jun 02, 2021, 05:39 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jun 01, 2021 | Sale | $32.50 | 15,141 | 492,083 | 4,208,789 | Jun 02, 2021, 05:39 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | Jun 02, 2021 | Sale | $31.86 | 6,215 | 197,999 | 4,202,871 | Jun 02, 2021, 05:39 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | May 25, 2021 | Sale | $32.88 | 6,572 | 216,094 | 4,272,759 | May 27, 2021, 07:41 PM | |
| RPTX | Repare Therapeutics Inc. | GADICKE ANSBERT | 10% Owner | May 26, 2021 | Sale | $32.76 | 24,036 | 787,399 | 4,250,327 | May 27, 2021, 07:41 PM |
Menu